| Schedule of segment reporting information |
| |
|
Three Months |
|
Three Months |
|
Six Months |
|
Six Months |
| |
|
Ended |
|
Ended |
|
Ended |
|
Ended |
| |
|
June 30,
2019 |
|
June 30,
2018 |
|
June 30,
2019 |
|
June 30,
2018 |
| Revenues |
|
|
|
|
|
|
|
|
| Real property operating |
|
$ |
264,889 |
|
|
$ |
278,872 |
|
|
$ |
531,515 |
|
|
$ |
575,495 |
|
| Medical related consulting services – related party |
|
|
111,434 |
|
|
|
141,996 |
|
|
|
125,694 |
|
|
|
141,996 |
|
| Development services and sales of developed products |
|
|
23,404 |
|
|
|
75,225 |
|
|
|
26,682 |
|
|
|
86,515 |
|
| |
|
|
399,727 |
|
|
|
496,093 |
|
|
|
683,891 |
|
|
|
804,006 |
|
| Depreciation and amortization |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
40,780 |
|
|
|
32,625 |
|
|
|
81,561 |
|
|
|
65,249 |
|
| Medical related consulting services |
|
|
4,766 |
|
|
|
3,991 |
|
|
|
7,706 |
|
|
|
7,997 |
|
| Development services and sales of developed products |
|
|
100,443 |
|
|
|
87,980 |
|
|
|
195,853 |
|
|
|
174,729 |
|
| |
|
|
145,989 |
|
|
|
124,596 |
|
|
|
285,120 |
|
|
|
247,975 |
|
| Interest expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
8,819 |
|
|
|
24,932 |
|
|
|
32,877 |
|
|
|
261,918 |
|
| Medical related consulting services |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Development services and sales of developed products |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| |
|
|
8,819 |
|
|
|
24,932 |
|
|
|
32,877 |
|
|
|
261,918 |
|
| Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Real property operating |
|
|
(3,690 |
) |
|
|
5,617 |
|
|
|
(102,379 |
) |
|
|
(232,083 |
) |
| Medical related consulting services |
|
|
(54,627 |
) |
|
|
16,456 |
|
|
|
(244,697 |
) |
|
|
(157,018 |
) |
| Development services and sales of developed products |
|
|
(230,406 |
) |
|
|
(196,896 |
) |
|
|
(478,188 |
) |
|
|
(297,028 |
) |
| Other (a) |
|
|
(4,150,100 |
) |
|
|
(1,168,992 |
) |
|
|
(8,118,488 |
) |
|
|
(2,208,655 |
) |
| |
|
$ |
(4,438,823 |
) |
|
$ |
(1,343,815 |
) |
|
$ |
(8,943,752 |
) |
|
$ |
(2,894,784 |
) |
| Identifiable long-lived
tangible assets at June 30, 2019 and December 31, 2018 |
|
June
30,
2019 |
|
|
December
31, 2018 |
|
| Real
property operating |
|
$ |
7,810,549 |
|
|
$ |
7,898,224 |
|
| Medical related
consulting services |
|
|
3,417 |
|
|
|
6,852 |
|
| Development
services and sales of developed products |
|
|
371,489 |
|
|
|
224,364 |
|
| |
|
$ |
8,185,455 |
|
|
$ |
8,129,440 |
|
| Identifiable long-lived
tangible assets at June 30, 2019 and December 31, 2018 |
|
June
30,
2019 |
|
|
December 31,
2018 |
|
| United
States |
|
$ |
7,907,804 |
|
|
$ |
7,898,806 |
|
| China |
|
|
277,651 |
|
|
|
230,634 |
|
| |
|
$ |
8,185,455 |
|
|
$ |
8,129,440 |
|
|
(a) |
The
Company does not allocate any interest expense and general and administrative expense
of its being a public company activities to its reportable segments as these activities
are managed at a corporate level. |
|